SCHEMBL6975443

SCHEMBL6975443

N#Cc1ccc(CCC(=O)N2CCc3cc(N)ccc32)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.54
MAPT P10636 4/20 0.48
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
MAPK1 P28482 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
TSHR P16473 3/20 0.44
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
RIPK1 Q13546 1/20 0.43
FPR1 P21462 2/20 0.42
FPR2 P25090 2/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
EP300 Q09472 2/20 0.41
TNF P01375 2/20 0.40
NOD1 Q9Y239 2/20 0.40
NOD2 Q9HC29 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6979722 0.93 TP53 (0.48) TP53MAPTNPC1RAB9AMAPK1
SCHEMBL7959087 0.93 TP53 (0.48) TP53MAPTNPC1RAB9AMAPK1
SCHEMBL6984975 0.83 DRD4 (0.57) TP53MAPTNPC1RAB9AMAPK1
SCHEMBL6974883 0.83 TP53 (0.41) TP53MAPTNPC1RAB9AMAPK1
SCHEMBL6986711 0.81 TSHR (0.45) TP53MAPTNPC1RAB9AMAPK1
SCHEMBL6977052 0.81 TP53 (0.39) TP53MAPTNPC1RAB9AMAPK1
SCHEMBL6979462 0.78 MAPT (0.58) TP53MAPTNPC1RAB9AMAPK1
SCHEMBL6978707 0.78 MAPT (0.58) TP53MAPTNPC1RAB9AMAPK1
SCHEMBL6979360 0.78 TP53 (0.42) TP53MAPTNPC1RAB9AMAPK1
SCHEMBL7956735 0.77 KCNJ1 (0.51) TP53MAPTNPC1MAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed